10/31/2024
3:16 PM | Athira Pharma (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
10/28/2024
11:15 PM | Athira Pharma (Filer)
| Form EFFECT | |
10/21/2024
5:24 AM | Athira Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/03/2024
8:50 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4/A | |
10/03/2024
6:07 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:08 PM | Athira Pharma (Issuer)
Worthington Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:10 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/03/2024
6:13 PM | Athira Pharma (Issuer)
San Martin Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:17 PM | Athira Pharma (Issuer)
Renninger Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:05 PM | Athira Pharma (Issuer)
Renninger Robert (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/17/2024
8:00 AM | Athira Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
6:47 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:48 PM | Athira Pharma (Issuer)
Worthington Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:49 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:50 PM | Athira Pharma (Issuer)
Lenington Rachel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:51 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:53 PM | Athira Pharma (Subject)
Litton Mark James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:15 PM | Athira Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/25/2024
6:21 PM | Athira Pharma (Issuer)
Romano Kelly A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:05 PM | Athira Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
5:54 PM | Athira Pharma (Issuer)
FLUKE JOHN M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
5:55 PM | Athira Pharma (Issuer)
PICKERING GRANT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
5:56 PM | Athira Pharma (Issuer)
Panzara Michael A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
5:58 PM | Athira Pharma (Issuer)
Kosacz Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:00 PM | Athira Pharma (Issuer)
JOHNSON JAMES A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:01 PM | Athira Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:03 PM | Athira Pharma (Issuer)
Romano Kelly A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:34 PM | Athira Pharma (Issuer)
San Martin Javier (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/16/2024
3:37 PM | Athira Pharma (Issuer)
San Martin Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
7:32 AM | Athira Pharma (Filer)
| Form DEF 14A | |
04/09/2024
7:34 AM | Athira Pharma (Filer)
| Form DEFA14A | |
04/09/2024
7:35 AM | Athira Pharma (Filer)
| Form ARS | |
03/28/2024
7:47 AM | Athira Pharma (Filer)
| Form PRE 14A | |
02/22/2024
3:34 PM | Athira Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/22/2024
3:15 PM | Athira Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/16/2024
3:46 PM | Athira Pharma (Issuer)
Lenington Rachel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:48 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:54 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:32 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4/A | |
02/16/2024
3:34 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 4/A | |
02/16/2024
3:37 PM | Athira Pharma (Issuer)
Worthington Mark (Reporting)
| Form 4/A | |
The pin that pops the AI bubble (Ad) My new documentary explores the background to this pattern and how and why I believe it will almost certainly repeat itself with the AI frenzy.
I urge you to watch it before you invest another cent. Again, to be clear, I’m no Chicken Little. Far from it.  So go here now to read my new report The Big AI Die-Up… while you still can. |
02/16/2024
3:38 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4/A | |
02/16/2024
3:40 PM | Athira Pharma (Issuer)
Lenington Rachel (Reporting)
| Form 4/A | |
01/08/2024
3:36 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:38 PM | Athira Pharma (Issuer)
Worthington Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:40 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:42 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:45 PM | Athira Pharma (Issuer)
MOEBIUS HANS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:35 PM | Athira Pharma (Issuer)
Lenington Rachel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
6:11 AM | Athira Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
4:24 PM | Athira Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:15 PM | Athira Pharma (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
